Investigation of the effect of trehalose on troponin and C-Reactive Protein in patients with myocardial infarctio
Phase 2
Not yet recruiting
- Conditions
- I21.1I21.2I21.3I21.9Condition 1: ST-elevation myocardial infarction. Condition 2: ST-elevation myocardial infarction. Condition 3: ST-elevation myocardial infarction. Condition 4: ST-elevation myocardial infarction. Condition 5: ST-elevation myocardial infarction.ST elevation (STEMI) myocardial infarction of anterior wallST elevation (STEMI) myocardial infarction of inferior wallST elevation (STEMI) myocardial infarction of other sitesST elevation (STEMI) myocardial infarction of unspecified siteAcute myocardial infarction, unspecified
- Registration Number
- IRCT20181022041407N9
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Patients with STEMI who refer to cath lab of Ghaem Hospital
Only one artery needs revascularization after angiography (and no need for more revascularization in the next 2 months)
Satisfaction for participation in research project.
Exclusion Criteria
Cardiogenic shock
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms does trehalose utilize to reduce troponin levels in STEMI patients?
How does trehalose compare to standard anti-inflammatory treatments in managing CRP in STEMI cases?
Which biomarkers correlate with improved outcomes in IRCT20181022041407N9 STEMI trials using trehalose?
What are the potential adverse events associated with trehalose administration in acute myocardial infarction?
Are there combination therapies involving trehalose that enhance cardioprotection in ST elevation myocardial infarction?
